This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:—
The practicing physicians of the United States are not taking full advantage of the excellent drug evaluation program of the A. M. A. The scope and thoroughness of this program were not appreciated by me until recently when another physician and myself were guests of the Council on Drugs at its annual meeting. The realization that many physicians are not using the Council's findings as reference prompts this letter. The Council, established in 1906, is composed of 18 members, each an authority in his specialty and carefully selected for the Council. All give unselfishly of their knowledge and freely of their time to make the Council's findings accurate and factual. At biweekly intervals new drugs are evaluated through careful analysis of all data and research information provided by the involved pharmaceutical company. In addition, Council-selected consultants are often asked for their opinions. The result is an unbiased
Leinbach SP. COUNCIL ON DRUGS. JAMA. 1959;169(1):69. doi:10.1001/jama.1959.03000180071023
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: